Insider · CIK 0001854362

Aggarwal Sumit

Reports to the SEC for 1 company · ARLINGTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001854362

Forms 4 and 5

Insider transactions

33 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-10	ELOXEloxx Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+329K sh	—	—	328,833
2026-02-28	ELOXEloxx Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+261K sh	$0.15	+$39.1K	1,672,756
2026-02-28	ELOXEloxx Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−261K sh	—	—	3,336,144
2026-01-24	ELOXEloxx Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+15K sh	—	—	1,411,810
2026-01-24	ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−15K sh	—	—	15,000
2025-09-19	ELOXEloxx Pharmaceuticals, Inc.A Award	Director, President and CEO	AAward	+1M sh	—	—	1,396,810
2025-09-19	ELOXEloxx Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+3.6M sh	—	—	3,597,090
2025-08-14	ELOXEloxx Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+197K sh	$0.00	+$19.688	396,810
2025-08-14	ELOXEloxx Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−60.4K sh	—	—	0
2025-08-14	ELOXEloxx Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−68.7K sh	—	—	0
2025-08-14	ELOXEloxx Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−25K sh	—	—	0
2025-08-14	ELOXEloxx Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−42.8K sh	—	—	0
2025-01-24	ELOXEloxx Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+30K sh	—	—	199,930
2025-01-24	ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−30K sh	—	—	30,000
2024-10-16	ELOXEloxx Pharmaceuticals, Inc.A Award	Director, President and CEO	AAward	+165K sh	—	—	169,930
2024-10-16	ELOXEloxx Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−42.8K sh	—	—	0
2024-10-16	ELOXEloxx Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+42.8K sh	—	—	42,790
2024-10-16	ELOXEloxx Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−35.6K sh	—	—	0
2024-10-16	ELOXEloxx Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+35.6K sh	—	—	35,580
2024-10-16	ELOXEloxx Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−24.8K sh	—	—	0
2024-10-16	ELOXEloxx Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+24.8K sh	—	—	24,810
2024-10-16	ELOXEloxx Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−68.7K sh	—	—	0
2024-10-16	ELOXEloxx Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+68.7K sh	—	—	68,700
2024-01-24	ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director, President and CEO	AAward	+60K sh	—	—	60,000
2023-01-25	ELOXEloxx Pharmaceuticals, Inc. · Stock Options (Right to Buy)A Award	Director, President and CEO	AAward	+68.7K sh	—	—	68,700
2022-02-06	ELOXEloxx Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+42.8K sh	—	—	42,790
2021-12-01	ELOXEloxx Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+279K sh	—	—	279,158
2021-12-01	ELOXEloxx Pharmaceuticals, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−81.9K sh	$0.72	−$59K	197,225
2021-12-01	ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−279K sh	—	—	0
2021-05-18	ELOXEloxx Pharmaceuticals, Inc. · Stock Options (Right to Buy)A Award	Director, President and CEO	AAward	+992K sh	—	—	992,409
2021-04-01	ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director, President and CEO	AAward	+223K sh	—	—	223,304
2021-04-01	ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director, President and CEO	AAward	+55.9K sh	—	—	279,158
2021-04-01	ELOXEloxx Pharmaceuticals, Inc. · Stock Options (Right to Buy)A Award	Director, President and CEO	AAward	+1.42M sh	—	—	1,423,238

Recent filings

Accepted (ET)
Jun 104
Aggarwal Sumit0001193125-26-266277
SEC(opens sec.gov)
May 84
Aggarwal Sumit0001193125-26-214890
SEC(opens sec.gov)

Companies

Eloxx Pharmaceuticals, Inc.Director, President and CEOELOX

Address

C/O ELOXX PHARMACEUTICALS, INC. P.O. BOX 274

ARLINGTON, MA, 02476